AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CRESCENT BIOPHARMA, INC. Director's Dealing 2017

Mar 13, 2017

33678_dirs_2017-03-13_7319d4d7-0b4b-442a-a976-e32c881138f6.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GLYCOMIMETICS INC (GLYC)
CIK: 0001253689
Period of Report: 2017-03-09

Reporting Person: Koenig Scott (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially owned	0	Direct